Sachs David C. sold IBRX
February 22, 2026 · Form 4 insider transaction
Sachs David C. sold 20,682 shares of ImmunityBio, Inc. at $8.70 per share, a transaction worth $179.9K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
20,682
Price
$8.70
Total value
$179.9K
InsiderSachs David C.
Role—
CompanyImmunityBio, Inc. (IBRX)
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 22, 2026
Filing dateFebruary 24, 2026
Shares owned after300,143
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On February 22, 2026, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on February 20, 2026 was the settlement price used to calculate the shares withheld.